As of 2026-03-29, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -101.82 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 43.50 GBP, the upside of Faron Pharmaceuticals Oy is -334.06%.
Based on its market price of 43.50 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 334.06%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -101.82 - -101.82 | -101.82 | -334.06% |
| P/E | (53.35) - (71.68) | (47.85) | -210.0% |
| DDM - Stable | (129.46) - (352.00) | (240.73) | -653.4% |
| DDM - Multi | (76.61) - (169.08) | (106.22) | -344.2% |
| Market Cap (mil) | 50.55 |
| Beta | 0.00 |
| Outstanding shares (mil) | 1.16 |
| Enterprise Value (mil) | 61.28 |
| Market risk premium | 5.98% |
| Cost of Equity | 12.11% |
| Cost of Debt | 5.00% |
| WACC | 9.99% |